ArticleMolecular cancer therapeutics2021

CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.

Tomohiro Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.